These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37630648)

  • 21. Status of vaccine research and development for enterotoxigenic Escherichia coli.
    Bourgeois AL; Wierzba TF; Walker RI
    Vaccine; 2016 Jun; 34(26):2880-2886. PubMed ID: 26988259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramuscularly Administered Enterotoxigenic
    Upadhyay I; Lauder KL; Li S; Ptacek G; Zhang W
    Microbiol Spectr; 2022 Aug; 10(4):e0147322. PubMed ID: 35762781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of porcine enterotoxigenic Escherichia coli (ETEC) ghosts and immunogenic analysis in a mouse model.
    Ran X; Chen X; Wang S; Chang C; Wen X; Zhai J; Ni H
    Microb Pathog; 2019 Jan; 126():224-230. PubMed ID: 30428380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.
    Luo Q; Vickers TJ; Fleckenstein JM
    Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservation and immunogenicity of novel antigens in diverse isolates of enterotoxigenic Escherichia coli.
    Luo Q; Qadri F; Kansal R; Rasko DA; Sheikh A; Fleckenstein JM
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003446. PubMed ID: 25629897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
    Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Analysis of Outer Membrane Vesicle Isolation Methods With an
    Reimer SL; Beniac DR; Hiebert SL; Booth TF; Chong PM; Westmacott GR; Zhanel GG; Bay DC
    Front Microbiol; 2021; 12():628801. PubMed ID: 33746922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin.
    Duan Q; Huang J; Xiao N; Seo H; Zhang W
    Appl Environ Microbiol; 2018 Jan; 84(2):. PubMed ID: 29079628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
    Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
    Svennerholm AM
    Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
    Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
    Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
    Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
    Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting peptide-enhanced antibody and CD11c
    Jiang X; Xia S; He X; Ma H; Feng Y; Liu Z; Wang W; Tian M; Chen H; Peng F; Wang L; Zhao P; Ge J; Liu D
    FASEB J; 2019 Feb; 33(2):2836-2847. PubMed ID: 30321067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.
    Lee T; Gutiérrez RL; Maciel M; Poole S; Testa KJ; Trop S; Duplessis C; Lane A; Riddle MS; Hamer M; Alcala A; Prouty M; Maier N; Erdem R; Louis Bourgeois A; Porter CK
    Vaccine; 2021 Sep; 39(39):5548-5556. PubMed ID: 34419306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization With Skp Delivered on Outer Membrane Vesicles Protects Mice Against Enterotoxigenic
    Hays MP; Houben D; Yang Y; Luirink J; Hardwidge PR
    Front Cell Infect Microbiol; 2018; 8():132. PubMed ID: 29765911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
    Seo H; Nandre RM; Nietfeld J; Chen Z; Duan Q; Zhang W
    PLoS One; 2019; 14(5):e0216076. PubMed ID: 31042746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
    Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization.
    Zhang C; Iqbal J; Gómez-Duarte OG
    Vet Microbiol; 2017 Apr; 202():90-100. PubMed ID: 26878971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.